{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:37:24Z","timestamp":1772627844690,"version":"3.50.1"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["J. Pharm. Pharm. Sci."],"abstract":"<jats:p>Asthma and allergies are closely related conditions affecting millions of people around the world. Current treatment options cover many classes of drugs for both acute and ongoing conditions. \u03b22-agonists, leukotriene modifiers, and corticosteroids represent some of the common types of drugs utilized in asthma management. These medications are often delivered via inhalation, oral, or parenteral methods, but each of these modalities faces challenges due to improper technique with inhalers, lessened oral bioavailability due to first-pass metabolism, and reduced compliance of injectable medicines. Transdermal drug delivery may offer a beneficial route of administration that overcomes these barriers as a painless, self-administered form that bypasses first-pass metabolism and can reduce dosing frequency with longer drug release profiles and reduced fluctuations in plasma drug levels. In this two-part mini-review series we will summarize the current literature on transdermal systems for asthma and allergy therapy. Here in Part 1, we cover \u03b22-agonists and discuss the potential of transdermal systems for these drugs. While the body of work with transdermal \u03b22-agonists for asthma treatment is limited, there is still evidence that transdermal systems for asthma has potential to greatly shift the field of asthma therapeutics.<\/jats:p>","DOI":"10.3389\/jpps.2026.15713","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:10:27Z","timestamp":1772604627000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Rethinking asthma therapy, part 1: transdermal delivery of \u03b22-agonists"],"prefix":"10.3389","volume":"29","author":[{"given":"Joseph","family":"Correa","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa","place":["Iowa City, IA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole K.","family":"Brogden","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa","place":["Iowa City, IA, United States"]},{"name":"Department of Dermatology, University of Iowa","place":["Iowa City, IA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.23736\/S0026-4806.21.07372-9","article-title":"Acute severe asthma: management and treatment","volume":"112","author":"Bosi At","year":"2021","journal-title":"Minerva Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1111\/all.16596","article-title":"Economic impact of allergic diseases and asthma\u2014the HEAD pan-european registry","volume":"80","author":"Agache","year":"2025","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajim.23633","article-title":"Medical costs and incremental medical costs of asthma among workers in the United States","volume":"67","author":"Bhattacharya","year":"2024","journal-title":"Am J Ind Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2500\/aap.2019.40.4253","article-title":"Classification of asthma","volume":"40","author":"Padem","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jaip.2017.05.001","article-title":"Asthma exacerbations: pathogenesis, prevention, and treatment","volume":"5","author":"Castillo","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B6","doi-asserted-by":"publisher","first-page":"107766","DOI":"10.1016\/j.rmed.2024.107766","article-title":"Choosing the right biologic treatment for individual patients with severe asthma \u2013 lessons learnt from picasso","volume":"234","author":"Terl","year":"2024","journal-title":"Respir Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2500\/aap.2019.40.4256","article-title":"Asthma in adults: principles of treatment","volume":"40","author":"Kwah","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.3390\/jcm13195775","article-title":"A review on asthma and allergy: current understanding on molecular perspectives","volume":"13","author":"Gohal","year":"2024","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.alit.2019.01.004","article-title":"Biological treatments for severe asthma: a major advance in asthma care","volume":"68","author":"Busse","year":"2019","journal-title":"Allergol Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","article-title":"Role of biologics in asthma","volume":"199","author":"McGregor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"CD013030","DOI":"10.1002\/14651858.CD013030.pub2","article-title":"Digital interventions to improve adherence to maintenance medication in asthma","volume":"6","author":"Chan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1111\/bph.15197","article-title":"Cough as an adverse effect on inhalation pharmaceutical products","volume":"177","author":"Chang","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1034\/j.1398-9995.2001.00100.x","article-title":"Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device","volume":"56","author":"Dubus","year":"2001","journal-title":"Allergy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.1472-8206.2003.00191.x","article-title":"Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma","volume":"17","author":"Dubus","year":"2003","journal-title":"Fundam and Clin Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1378\/chest.91.2.207","article-title":"Cough and wheezing from beclomethasone aerosol","volume":"91","author":"Shim","year":"1987","journal-title":"Chest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chest.2016.03.041","article-title":"Systematic review of errors in inhaler use: has patient technique improved over time?","volume":"150","author":"Sanchis","year":"2016","journal-title":"CHEST"},{"key":"B17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41533-025-00422-0","article-title":"Inhalation technique-related errors after education among asthma and COPD patients using different types of inhalers \u2013 systematic review and meta-analysis","volume":"35","author":"Marko","year":"2025","journal-title":"Npj Prim Care Respir Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mser.2016.03.001","article-title":"Microneedle arrays as transdermal and intradermal drug delivery systems: materials science, manufacture and commercial development","volume":"104","author":"Larra\u00f1eta","year":"2016","journal-title":"Mater Sci Eng R: Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1208\/s12248-017-0054-z","article-title":"Challenges and future prospects for the delivery of biologics: oral mucosal, pulmonary, and transdermal routes","volume":"19","author":"Morales","year":"2017","journal-title":"AAPS J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13346-015-0237-z","article-title":"Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation","volume":"5","author":"Lutton","year":"2015","journal-title":"Drug Deliv Transl Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1001\/jama.2020.21974","article-title":"Managing asthma in adolescents and adults: 2020 asthma guideline update from the national asthma education and prevention program","volume":"324","author":"Cloutier","year":"2020","journal-title":"JAMA"},{"key":"B23","article-title":"Global strategy for asthma management and prevention","author":"Committee","year":"2024"},{"key":"B24","first-page":"569","article-title":"Ketotifen fumarate and salbutamol sulphate combined transdermal patch formulations: in vitro release and Ex vivo permeation studies","volume":"75","author":"Yousuf","year":"2013","journal-title":"Indian J Pharm Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/02652048.2022.2060362","article-title":"Sustained delivery of salbutamol from cubosomal gel for management of paediatric asthma: in vitro and in vivo evaluation","volume":"39","author":"Zhang","year":"2022","journal-title":"J Microencapsulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s13346-019-00688-1","article-title":"A novel nanogel loaded with chitosan decorated bilosomes for transdermal delivery of terbutaline sulfate: artificial neural network optimization, in vitro characterization and in vivo evaluation","volume":"10","author":"El Menshawe","year":"2020","journal-title":"Drug Deliv Translational Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jps.2600811007","article-title":"Transdermal drug delivery systems of albuterol: in vitro and in vivo studies","volume":"81","author":"Gokhale","year":"1992","journal-title":"J Pharm Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"E-TN1","DOI":"10.1208\/pt0201_tn1","article-title":"Physical and chemical permeation enhancers in transdermal delivery of terbutaline sulphate","volume":"2","author":"Murthy","year":"2001","journal-title":"AAPS PharmSciTech"},{"key":"B29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijpharm.2004.08.018","article-title":"Clinical pharmacokinetic and pharmacodynamic evaluation of transdermal drug delivery systems of salbutamol sulfate","volume":"287","author":"Murthy","year":"2004","journal-title":"Int J Pharmaceutics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0378-5173(97)00209-3","article-title":"Drug delivery from a liquid crystalline base across visking and human stratum corneum","volume":"157","author":"Carr","year":"1997","journal-title":"Int J Pharmaceutics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijpharm.2007.04.004","article-title":"Combined effects of iontophoretic and chemical enhancement on drug delivery: II. Transport across human and murine skin","volume":"341","author":"Nolan","year":"2007","journal-title":"Int J Pharmaceutics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0378-5173(03)00108-x","article-title":"Iontophoretic and chemical enhancement of drug delivery: part I: across artificial membranes","volume":"257","author":"Nolan","year":"2003","journal-title":"Int J Pharmaceutics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1081\/ddc-120015355","article-title":"In vitro evaluation of the release of albuterol sulfate from polymer gels: effect of fatty acids on drug transport across biological membranes","volume":"28","author":"Chisty","year":"2002","journal-title":"Drug Development Ind Pharm"},{"key":"B34","article-title":"System for transdermal albuterol administration","author":"Farhadieh","year":"2025","journal-title":"EP Patent EP 0431519 A1"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1163\/156856208785540118","article-title":"Poly(hydroxyethyl methacrylate)-based co-polymeric hydrogels for transdermal delivery of salbutamol sulphate","volume":"19","author":"Suhag","year":"2008","journal-title":"J Biomater Sci Polym Ed"},{"key":"B36","first-page":"334","article-title":"Iontophoretic transdermal delivery of salbutamol: methyl-orange ion-pair","volume":"53","author":"Sant","year":"1998","journal-title":"Pharmazie"},{"key":"B37","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1208\/pt0804107","article-title":"Enhanced transdermal delivery of salbutamol sulfate via ethosomes","volume":"8","author":"Bendas","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1081\/ddc-100108368","article-title":"Formulation and evaluation of controlled-release transdermal patches of theophylline\u2013salbutamol sulfate","volume":"27","author":"Murthy","year":"2001","journal-title":"Drug Development Ind Pharm"},{"key":"B39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1021\/js9502783","article-title":"Quantitative evaluation of aqueous isopropyl alcohol enhancement on skin flux of terbutaline (sulfate). 2. Permeability contributions of equilibrated drug species across human skin in vitro","volume":"85","author":"Liu","year":"1996","journal-title":"J Pharm Sci"},{"key":"B40","first-page":"34","article-title":"Statistical optimization of transdermal drug delivery system of terbutaline sulfate by factorial analysis","volume":"139","author":"Manna","year":"2000","journal-title":"Boll Chim Farm"},{"key":"B41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1208\/pt060225","article-title":"The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins","volume":"6","author":"Panigrahi","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.2042-7158.1996.tb03909.x","article-title":"Terbutaline transdermal delivery: preformulation studies and limitations of in-vitro predictive parameters","volume":"48","author":"Tenjarla","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1600-0536.1996.tb02294.x","article-title":"Sensitization of mice to topically applied drugs: albuterol chlorpheniramine, clonidine and nadolol","volume":"35","author":"Kalish","year":"1996","journal-title":"Contact Dermatitis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/archderm.143.12.1589","article-title":"Discoid and subacute lupus erythematosus treated with 0.5% R-Salbutamol cream","volume":"143","author":"Wulf","year":"2007","journal-title":"Arch Dermatol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/clinchem\/35.5.889","article-title":"Albuterol: transdermal absorption and fingerprick blood-sample contamination from nebulizers","volume":"35","author":"Badcock","year":"1989","journal-title":"Clin Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1023\/a:1015854411498","article-title":"Quantitative evaluation of aqueous isopropanol enhancement of skin flux of terbutaline (sulfate). I. Ion associations and species equilibria in the formulation","volume":"9","author":"Liu","year":"1992","journal-title":"Pharm Res"},{"key":"B47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-031-66776-3","article-title":"Asthma and COPD: a focus on \u03b2-Agonists \u2013 past, present and future","volume-title":"Adrenoceptors","author":"Baker","year":"2024"},{"key":"B48","first-page":"147","article-title":"Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN-078, in childhood asthma","volume":"74","author":"Iikura","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/BF02718135","article-title":"Prolonged treatment with oral and inhaled tulobuterol does not induce airways tachyphlaxis","volume":"168","author":"Patel","year":"1990","journal-title":"Lung"},{"key":"B50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2332\/allergolint.11-RA-0358","article-title":"Transdermal tulobuterol patch, a long-actingbeta(2)-agonist","volume":"61","author":"Tamura","year":"2012","journal-title":"Allergol Int"},{"key":"B51","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00316473","article-title":"The pharmacokinetics of the \u03b22-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation","volume":"44","author":"Uematsu","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/1440-1681.12683","article-title":"A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma","volume":"44","author":"Inoue","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2152656720980416","DOI":"10.1177\/2152656720980416","article-title":"Comparison of 12-Week additional effect features of formoterol Co-Inhalation and tulobuterol patch on budesonide inhalation in elderly patients with asthma","volume":"11","author":"Fukahori","year":"2020","journal-title":"Allergy and Rhinology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1248\/yakushi.122.57","article-title":"Development of transdermal formulation of tulobuterol for the treatment of bronchial asthma","volume":"122","author":"Kato HN","year":"2002","journal-title":"Yakugaku Zasshi"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/rrtd.s34031","article-title":"Long-term safety, efficacy, and patient acceptability of the tulobuterol patch","volume":"2","author":"Ichikawa","year":"2013","journal-title":"Res Rep Transdermal Drug Deliv"},{"key":"B56","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4168\/aair.2019.11.2.222","article-title":"Multicenter adherence study of asthma medication for children in Korea","volume":"11","author":"Kim","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2332\/allergolint.08-OA-0060","article-title":"Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma","volume":"58","author":"Hozawa","year":"2009","journal-title":"Allergol Int"},{"key":"B58","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.pupt.2011.06.002","article-title":"Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-Assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: a randomized crossover study","volume":"24","author":"Abe","year":"2011","journal-title":"Pulm Pharmacol and Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.pupt.2006.08.004","article-title":"Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal \u03b22-agonist","volume":"20","author":"Akamatsu","year":"2007","journal-title":"Pulm Pharmacol and Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.rmed.2009.09.012","article-title":"Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD","volume":"104","author":"Ichinose","year":"2010","journal-title":"Respir Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.rmed.2007.05.001","article-title":"Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch","volume":"101","author":"Tamura","year":"2007","journal-title":"Respir Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/02770900601180321","article-title":"Addition of transdermal or inhaled long-acting \u03b2 2-Agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler","volume":"44","author":"Kobayashi","year":"2007","journal-title":"J Asthma."},{"key":"B63","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pupt.2007.05.004","article-title":"Comparison of bronchodilatory properties of transdermal and inhaled long-acting \u03b22-agonists","volume":"21","author":"Yamagata","year":"2008","journal-title":"Pulm Pharmacol and Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/02770900600758432","article-title":"Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids","volume":"43","author":"Fujimoto","year":"2006","journal-title":"J Asthma."},{"key":"B65","doi-asserted-by":"publisher","first-page":"820","DOI":"10.15036\/arerugi.61.820","article-title":"Clinical effects of budesonide\/formoterol combination drug in elder patients with asthma compared with budesonide plus tulobuterol patch combination treatment","volume":"61","author":"Onari","year":"2012","journal-title":"Jpn J Allergol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e14469","DOI":"10.1016\/j.heliyon.2023.e14469","article-title":"Fabricating transdermal film formulations of montelukast sodium with improved chemical stability and extended drug release","volume":"9","author":"Aashli","year":"2023","journal-title":"Heliyon"},{"key":"B67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/pharmacy10050106","article-title":"Medication adherence and compliance: recipe for improving patient outcomes","volume":"10","author":"Aremu","year":"2022","journal-title":"Pharmacy"},{"key":"B68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/medicina61010153","article-title":"Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life","volume":"61","author":"Religioni","year":"2025","journal-title":"Medicina"},{"key":"B69","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s13346-021-01047-9","article-title":"Fabrication of pure-drug microneedles for delivery of montelukast sodium","volume":"12","author":"Azizoglu","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1248\/bpb.29.146","article-title":"Effects of solvents on skin permeation of formoterol fumarate","volume":"29","author":"Kakubari","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"B71","doi-asserted-by":"publisher","first-page":"147229","DOI":"10.1016\/j.ijbiomac.2025.147229","article-title":"Chitosan-based dual-release core\u2013shell microneedle patches for sequential transdermal delivery of hydrophilic and hydrophobic drugs: an in vitro approach","volume":"327","author":"Babapour","year":"2025","journal-title":"Int J Biol Macromolecules"},{"key":"B72","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijpharm.2015.08.094","article-title":"Iontophoretic delivery of lipophilic and hydrophilic drugs from lipid nanoparticles across human skin","volume":"495","author":"Charoenputtakun","year":"2015","journal-title":"Int J Pharmaceutics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2302406","DOI":"10.1002\/adhm.202302406","article-title":"An ultraswelling microneedle device for facile and efficient drug loading and transdermal delivery","volume":"13","author":"Li","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"B74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jconrel.2014.02.007","article-title":"Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs","volume":"180","author":"McCrudden","year":"2014","journal-title":"J Controlled Release"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1021\/mp400359w","article-title":"Microneedle integrated transdermal patch for fast onset and sustained delivery of lidocaine","volume":"10","author":"Kochhar","year":"2013","journal-title":"Mol Pharmaceutics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1177\/1060028015583893","article-title":"Alternate routes of administration of antidepressant and antipsychotic medications","volume":"49","author":"Kaminsky","year":"2015","journal-title":"Ann Pharmacother"},{"key":"B77","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.mattod.2022.12.007","article-title":"Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications","volume":"63","author":"Bauleth-Ramos","year":"2023","journal-title":"Mater Today"},{"key":"B78","article-title":"Design and optimization of dosage regimens: pharmacokinetic data","volume-title":"Goodman and gilman's: the pharmacological basis of therapeutics","author":"Thummel","year":"2017"},{"key":"B79","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/gels9070523","article-title":"Polymer-based hydrogels applied in drug delivery: an overview","volume":"9","author":"Thang","year":"2023","journal-title":"Gels"},{"key":"B80","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s11095-011-0524-4","article-title":"Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action","volume":"29","author":"Zhang","year":"2012","journal-title":"Pharm Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"126350","DOI":"10.1016\/j.ijpharm.2025.126350","article-title":"Citric acid\u2013crosslinked carboxymethyl cellulose hydrogel microneedles enable gentle loading and rapid transdermal delivery of insulin","volume":"686","author":"Zhang","year":"2025","journal-title":"Int J Pharmaceutics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1021\/acs.molpharmaceut.5b00765","article-title":"Improvement of transdermal delivery of Exendin-4 using novel tip-loaded microneedle arrays fabricated from hyaluronic acid","volume":"13","author":"Liu","year":"2016","journal-title":"Mol Pharmaceutics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejpb.2016.06.006","article-title":"Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer\u2019s disease","volume":"105","author":"Kim","year":"2016","journal-title":"Eur J Pharmaceutics Biopharmaceutics"}],"container-title":["Journal of Pharmacy &amp; Pharmaceutical Sciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/jpps.2026.15713\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:10:30Z","timestamp":1772604630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/jpps.2026.15713\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":83,"alternative-id":["10.3389\/jpps.2026.15713"],"URL":"https:\/\/doi.org\/10.3389\/jpps.2026.15713","relation":{},"ISSN":["1482-1826"],"issn-type":[{"value":"1482-1826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"15713"}}